ORMP - Oramed Pharmaceuticals Inc.

Gainer Stock Signal: ORMP
Gainer Signal for 08-13-2022
Loading Chart ORMP

Stock Signal Information


Gainer Stock Signal: ORMP
Report Date: 08-13-2022
Company: Oramed Pharmaceuticals Inc. (ORMP)
Sector: Healthcare
Industry: Biotechnology

ORMP Technical Analysis

Company Contact

Oramed Pharmaceuticals Inc. (ORMP)
1185 Avenue of the Americas Ste 228
New York City, NEW YORK 10036
Phone: 16468441164
Website: http://www.oramed.com
CEO: Mr. Nadav Kidron

ORMP, Oramed Pharmaceuticals Inc.

ORMP Oramed Pharmaceuticals Inc. Logo Image

NASDAQ, Nasdaq Capital Market

Company Profile

Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the use of orally ingestible capsules or pills for delivery of polypeptides. Its product portfolio includes ORMD-0801, which completed phase II clinical trials is an orally ingestible insulin capsule for the treatment of diabetes; and ORMD-0901 that completed phase I clinical trials is an oral glucagon-like peptide-1 analog capsule for the treatment of type 2 diabetes. It is also developing a weight loss treatment in the form of an oral leptin capsule. The company was formerly known as Integrated Security Technologies, Inc. and changed its name to Oramed Pharmaceuticals Inc. in April 2006. Oramed Pharmaceuticals Inc. was founded in 2002 and is based in New York, New York.

Top Stock Signals

free stock market signals, free trading signals, free stock option signals

About Top Stock Signals

Good stock signals have been found on this server. That is all we know.

Phone: +1 (407) 559-7228
Email: [email protected]

About Us | Newsletter | Members

Most Active
Top Gainers
Top Losers